Lorillard — Investor Day (May 2011)
134 slides from Lorillard's investor day presentation, May 4, 2011
Slide 1: Investor Day May 4, 2011
Investor Day May 4, 2011 1
Slide 2: Agenda
Agenda Introduction Bob Bannon — Director, IR Strategic Review Murray Kessler Chairman, President & CEO Break Litigation / Regulatory Ron Milstein Overview SVP, General Counsel Financial Strategy David Taylor EVP, Chief Financial Officer Q&A All 2
Slide 3: Safe Harbor Disclaimer
Safe Harbor Disclaimer You are cautioned that certain statements made in this presentation are “forward-looking” statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include, without limitation, any statement that may project, indicate or
Slide 4: Murray S. Kessler, Chairman, President and CEO
Murray S. Kessler Chairman, President and Chief Executive Officer 4
Slide 5: Who is Lorillard?
Who is Lorillard? 5
Slide 6: By the Numbers
By the Numbers • Third largest tobacco company in the U.S. • 2010 Net sales — $5.9 billion • 2010 Operating profit — $1.7 billion • 2010 Earnings per share — $6.78 • $3.5 billion cash returned to shareholders in first 2.5 years as a stand-alone public company • 2,700 employees Source: Lorillard 2010
Slide 7: Strong Brand Portfolio Is Led By Newport
Strong Brand Portfolio Is Led By Newport Newport ® Brand 2010 Lorillard Net Sales Breakdown by Brand Others 10% #1 Menthol Brand in U.S 2010 Sales: $5.9 billion 35% share of menthol marketarket #2 Cigarette Brand in U.S. 10.5% share of market Newport Primary Driver of Profitabilityy 90% Other Brands
Slide 8: Newport Has Two of the Top Five SKUs in the Cigarette Category
Newport Has Two of the Top Five SKU’s in the Cigarette Category Q1 2011 Year % Rank Packing Units (B) Chg 1 Marlboro Gold King Box 6.47 -9.6 2 Marlboro King Box 4.25 -6.9 3 Newport Menthol King Box 3.29 -3.4 4 Newport Menthol 100 Box 3.06 10.3 5 Marlboro Gold 100 Box 1.93 -13.9 Source: Lorillard pro
Slide 9: By Key Measures Lorillard has Beaten the Competition
By Key Measures Lorillard has Beaten the Competition Altria Reynolds Cigarettes revenue CAGR (‘07-’10) 7.3% -1.2% -2.9% Cigarettes volume CAGR (‘07-’10) +1.5% -7.0% -7.4% Cigarettes market share change (‘07-’10) +2.3 pts. -2.6 pts. -1.8 pts. Source: Company filings. 9
Slide 10: Regarding Volume, it's Been No Comparison!
Regarding Volume, it’s Been No Comparison! Volume Change 2005 — 2010 (Billions of Units) 10 +2.2 Altria Reynolds 0 -10 -20 -30 -30 -40 -50 -45 Source: Company filings. 10
Slide 11: Industry Week Ranked Lorillard 2010 Best Manufacturing Company
Industry Week Ranked Lorillard the 2010 “Best Manufacturing Company” in America
Slide 12: 2011 Is Off to a Good Start
2011 Is Off to a Good Start Q1 2011 Change vs. Q1 2010 Total Unit Volume +9.5% Net Sales +12.9% Lorillard Retail Market Share +1.5 pts. Net Income +6.9% Earnings Per Share +14.0% Source: Lorillard Q1 earnings release, April 26, 2011. 12
Slide 13: But Lorillard Is A Lot More Than Numbers!
But Lorillard Is A Lot More Than Numbers! 13
Slide 14: Years of Tradition
250 Years of Tradition
Slide 15: newport pleasure
newport pleasure
Slide 16: Superior Products, Superior & Consistent Advertising
Superior Products Superior & Consistent Advertising 16
Slide 17: Net Promoter Score Is a Leading Way to Measure Brand Strength
A Net Promoter Score (NPS) Is a Leading Way to Measure Brand Strength “How likely is it that you would recommend product X to a friend or colleague?” Responses are classified into promoters, passives and detractors Extremely Extremely Likely Unlikely 10 9 8 7 6 5 4 3 2 1 0 Promoter Passive Detractor
Slide 18: Newport Has a Very High Net Promoter Score
Newport Has a Very High Net Promoter Score NPS Score Newport Cigarettes Cigars Chewing Gum Breath Mint Overall CPG Coffee Beverage Average Average Average Average Average Average Average Source: 2010 Lorillard Adult Consumer Survey and research company benchmarks. 18
Slide 19: A Unique Consumer Franchise
And a Unique Consumer Franchise Index to U.S. Demographic Overview Newport Menthol Non-Menthol Male 111 99 117 Female 90 101 84 Large Metro 121 105 89 Non-Metro 65 90 133 Northeast 173 123 85 South 108 121 110 Midwest 97 98 108 West 29 48 88 White 49 78 120 African American 447 259 20 Source: 2008 N
Slide 20: Managed at Retail by a Dedicated Sales Force
Managed at Retail by a Dedicated Sales Force • Nearly 1,000 people strong • Calling on more than 250,000 stores • Executing retail promotions, point-of-sale advertising, retail contracts • We believe the best relationships in the industry 20
Slide 21: Produced by World-Class Manufacturing
Produced by World-Class Manufacturing • 38 billion cigarettes per year • 760 million cigarettes per week • 152 million per day • Now 24 hours per day With a 99.99% Delivery Accuracy 21
Slide 22: Using Proprietary Tobacco Sourcing and Blends
Using Proprietary Tobacco Sourcing and Blends • 65 to 75 million pounds sourced annually • From 7 countries around the world • The Lorillard “Blends” — Only the Best • Aged up to two years before production 222
Slide 23: Entered Strategic Planning Process From a Position of Strength
Therefore, Entered Strategic Planning Process From a Position of Strength • Superior Financials • Strong Brand Equity • Superior Product • Strong Organization 23
Slide 24: Followed a Robust and Thorough Process
Followed a Robust and Thorough Process Customer Input NACS AWMA Shareholder Key Customers Consumer Input Input Proprietary survey Met with 60% of Ongoing consumer panels active shareholders Strategic Review Analytics Regulator Input Retail pricing trends Segment analysis Political Leaders Competitiv
Slide 25: Addressed the Following Key Questions
Addressed the Following Key Questions: 1. Can we sustain our core business success? 2. Can we grow beyond our current core business? 3. Do we have the capabilities to successfully pursue additional growth opportunities? 4. Will the litigation or regulatory environment impact this potential? 5. Can w
Slide 26: Question #1: Can we sustain our core business success?
Question #1 Can we sustain our core business success?
Slide 27: Lorillard Narrowly Competes within the Domestic Tobacco Industry
Lorillard Narrowly Competes within the Domestic Tobacco Industry U.S. Tobacco Market Segmentation
Slide 28: Domestic Cigarette Volume Continues to Decline
Overall, Domestic Cigarette Volume Continues to Decline
Slide 29: Competing in a Declining Market With a Unique Product Portfolio
Lorillard Competes Within this Declining Market With a Unique Product Portfolio
Slide 30: Strong Leadership Position With Full-Flavor Menthol Cigarettes
And Maintains a Strong Leadership Position With Full-Flavor Menthol Cigarettes 2010 Total: 288B Units Premium Premium Premium Premium Full Flavor Non-Full Flavor Full Flavor Non-Full Flavor Discount Menthol Menthol Non-Menthol Non-Menthol 46B Units 21B Units 47B Units 97B Units 78B Units Newport Sha
Slide 31: Segmentation by Geography Illustrates Our Core
Further Segmentation by Geography Illustrates Our Core 2010 Total: 288B Units Premium Premium Full Flavor Non-Full Flavor Premium Premium Menthol Menthol Full Flavor Non-Full Flavor Discount Core Markets 30B Total Units 12B Total Units Non-menthol Non-Menthol 78B Units Newport Share: Newport Share:
Slide 32: Strongest Segments Dramatically Outperforming Most Others
The Segments Where We are Strongest Are Dramatically Outperforming Most Other Segments Volume Change 2005 — 2010 Volume FF M FF M NFF M NFF M FF NM FF NM NFF NM NFF NM (Billion Units) Core Non-Core Core Non-core Core Non-Core Core Non-Core Discount -1 1 -3 -5 -10 -9 -13 -16 -17 ‘05 — ‘10 CAGR -0.4%
Slide 33: Volume Stability of the Core Has Driven Our Success
It Is Volume Stability of the Core and Our Stability in the Core That Has Driven Our Success Premium Full-Flavor Menthol, Core States Volume (Units) 32.7B 32.7B 32.9B 30.5B 30.2B 100% All 80% Other 60% 40% Newport Newport Newport Newport Newport 20% 0% 2006 2007 2008 2009 2010 Newport Share of Premi
Slide 34: Strong Brand and Consistent Support Drives Stability
Our Strong Brand and Consistent Support Drives Our Stability Consumer-preferred Product Priced Competitively 50-year Campaign 34
Slide 35: Newport Outperforms on All Critical Product Perceptions
For Example, Newport Outperforms on All Critical Product Perceptions in the Core Six Most Important Decision Criteria for a Premium Brand Newport Ranking vs. Consumer Feedback Competition* Has the strength of flavor I most like #1 Has the best taste #1 Tastes the same every time #1 The brand I’ve sm
Slide 36: Newport Leads Along All Phases of the Adoption Cycle
Newport Leads Along All Phases of the Adoption Cycle in the Core Brand Trial Brand Usage Newport Marlboro Camel Kool Salem Newport Marlboro Camel Kool Salem Source: 2010 Lorillard Adult Consumer Survey. 36 All references to consumers or smokers refer to adult consumers and adult smokers
Slide 37: The Brand Appears to Have Strengthened Over Time
The Brand Appears to Have Strengthened Over Time Purchase behavior if Newport is not available 2002 Consumer Study 2010 Consumer Survey 85 71 Go to another Go to another store to find store to find Newport Newport Newport Smokers Primary Brand Newport smokers in Premium Menthol Full-Flavor, Core geo
Slide 38: Newport Remains a Brand of Choice Among Adult Smokers
And as a Result, Newport Remains a Brand of Choice Among Adult Smokers Age 18-25 Newport Adult Smokers Age 18-25 Index to Total 18+ Share Source: National Survey on Drug Use and Health (NSDUH) 2002-2009 38
Slide 39: Stability Should Allow Lorillard to Continue Gaining Share
This Stability in a Declining Industry Should Allow Lorillard to Continue Gaining Market Share Lorillard Retail Market Share 12.9% 11.8% 11.0% 10.0% 10.4% 9.2% 9.6% 8.7% 9.0% Source: Lorillard proprietary retail database (“EXCEL”). 39
Slide 40: Question #1 Answer: Stay the Course
Question #1 Can we sustain our core business success? Yes...Lorillard will: Stay the course in product strategy Stay the course in messaging Stay the course in promotion strategy 40
Slide 41: Question #2: Can we grow beyond our current core business?
Question #2 Can we grow beyond our current core business? 41
Slide 42: Sustained Profitable Growth Companies Lead in Their Core
Companies with Sustained, Profitable Growth Lead in Their Core and Expand Selectively Percent of Public G7 Companies Considered 100% Other New-To-World Business Model Or Market Multiple Strong Cores Core Redefinition 80% Core Performance & 60% Single Strong Core Adjacency Expansion 0% Source: “Profi
Slide 43: Cigarette and OTP Opportunities Are Most Related to Our Core
Cigarette and OTP Opportunities Are Most Related to Our Core 3 Steps Unrelated 2 Steps Diversification Core 1 Step Tobacco MST related Other cigarette Other CPG Full flavor adjacencies (energy drinks, sub-segments Cigars menthol cigarettes (lighters, etc.) etc.) Other OTP International 43
Slide 44: Close-In Cigarette Adjacencies Represent Huge Opportunity
Close-In Cigarette Adjacencies Represent Huge Opportunity for Lorillard U.S. Cigarette Segmentation 100% Other Other 80% RJR RJR 60% Altria 40% Altria 20% 0% Non-Menthol Cigarettes Menthol Cigarettes 44 Source: Lorillard proprietary retail database (“EXCEL”).
Slide 45: Opportunity To Gain Share in Non-Core Geographies
There Is an Opportunity To Gain Share in Non-Core Geographies Premium Full-Flavor Menthol Volume Volume (Units) 2010 30B 16B All Other Brands All Other Brands Newport 74% Newport 41% Source: Lorillard proprietary retail database (“EXCEL”). 45
Slide 46: Leadership Position in Full-Flavor Menthol Outside Core
We Already Have a Leadership Position in Full-Flavor Menthol Outside Our Core Geographies Market Share of Premium Full-Flavor Menthol Non-Core Newport Marlboro Kool Camel Salem Source: Lorillard proprietary retail database (“EXCEL”). 46
Slide 47: Brand Equity Is Just as Strong in Non-Core Geographies
And Our Brand Equity Is Just as Strong in Non-Core Geographies Premium Full-Flavor Menthol — Net Promoter Score Newport Driven NPS S Score By Produ Product PerformancePerforman How likely would you be to recommend this brand to someone else? Source: 2010 Lorillard Adult Consumer Survey. 4 47
Slide 48: We Lag in Trial in the Non-Core
However, Despite Our Product Preference and Leading Share, We Lag in Trial in the Non-Core Premium Full-Flavor Menthol, Non-Core Geographies Brand Trial Brand Usage 100% 100% 81.7 78.0 80% 72.0 69.5 80% 67.9 61.2 61.0 60% 60% 40.0 40% 40% 34.4 29.8 20% 20% 0% 0% Marlboro Kool Newport Salem Camel Mar
Slide 49: Significantly Different Go-to-Market Strategy
This Is the Result of a Significantly Different Go-to-Market Strategy Core Non-Core % Volume on Buy Downs 85% 0-80% Price Gap to Leading Up to $0.70 parity Competitor higher Source: Lorillard and competitive retail market data, as of April 15, 2011. 49
Slide 50: Test Markets Indicate Geographic Expansion Can Be Profitable
Test Markets Indicate Geographic Expansion Can Be Accomplished Profitably Newport Test Market Results Wave II (2 states) +24.9 Wave I (2 states) +31.1 ptss. pts. Pre — Post — Pre — Post — 12 months 12 months 12 months 7 months Average Payback of approximately 15 months or less Source: Lorillard prop
Slide 51: Improving Our Position In Non-Full Flavor Menthol
Another Opportunity Is Improving Our Position In Non-Full Flavor Menthol Volume (Units) 2010 12B 9B 100% 80% 60% All Other Brands 40% 20% Newport 0% Non-Full-Flavor Non-Full-Flavor Premium Menthol Core Premium Menthol Non-Core Newport Share 17% (#2) 3% (#6) Source: Lorillard proprietary retail datab
Slide 52: Brand Equity Is Not as Strong in Non-Full-Flavor
In This Case, Our Brand Equity is Not as Strong Premium Menthol Newport NPS Scores Full-Flavor Non-Full-Flavor How likely would you be to recommend this brand to someone else? Source: 2010 Lorillard Adult Consumer Survey. 5 52
Slide 53: Consumer Data Suggests a Product Issue
Consumer Data Suggests a Product Issue Premium Non-Full-Flavor Menthol Brand Trial Brand Usage 100% 100% 81.7 80% 73.4 80% 69.2 65.6 61.9 57.7 60% 60% 48.1 37.5 40% 40% 26.2 19.6 20% 20% 0% 0% Marlboro Newport Salem Kool Camel Marlboro Camel Newport Salem Kool Source: 2010 Lorillard Adult Consumer S
Slide 54: Opportunity to Develop a More Widely Accepted Non-Full Flavor Product
Just One Example White Tip Newport 80% of Category There Is an Opportunity to Develop a More Widely Accepted Non-Full Flavor Product 54
Slide 55: Large Opportunity in Non-Menthol Premium Full-Flavor
There Is Also a Large Opportunity in Non-Menthol Premium Full-Flavor Non-Menthol, All States Volume (Units) 2010 47B Other Winston Camel Marlboro Source: Lorillard proprietary retail database (“EXCEL”). 55
Slide 56: With Price Support, Smokers Willing to Try Newport
With Price Support, Smokers Indicate a Willingness to Try Newport Percent of Smokers Very Willing to Try Newport Non-Menthol Non-Menthol Smokers 16% Trial and 5% Conversion Translates to 0.5 pts of Industry Share (1.5B units a year) Trial at Trial at Trial at Full Price $1/Pack $2/Pack Discount Disc
Slide 57: Newport Non-Menthol Is a Business Building Opportunity
Newport Non-Menthol Is a Business Building Opportunity 57
Slide 58: Takes Into Account Learnings From the Past
That Takes Into Account Learnings From the Past • Builds from a position of brand strength • Makes sufficient investment for trial • Utilizes consumer feedback 58
Slide 59: Newport Non-Menthol Introductory Price In-Line with Industry Practice
The Newport Non-Menthol Introductory Price Is In-Line with Industry Practice 59 Source: Greensboro, NC convenience store retail display, April 15, 2011.
Slide 60: Newport Non-Menthol Gaining Strong Trial
And, Importantly is Allowing Newport Non-Menthol to Gain Strong Trial Initial Newport Non-Menthol Monthly Retail Market Share Source: Lorillard proprietary retail database (“EXCEL”). 60
Slide 61: Source of Business Survey Gives Confidence in Reaching Full Price
Newport Non-Menthol Source of Business Survey Gives Us Confidence in Reaching Full Price Over Time Newport Non-Menthol Source of Volume Primary Reason for Future Intent to Purchase 26% #1 — Taste 60% 74% Discount Premium #2 — Price 31% Source: Lorillard Newport Non-Menthol Source of Business Survey,
Slide 62: Two-Thirds of Non-Menthol Buyers Adopted the Brand
More Than Two-Thirds of All Newport Non-Menthol Buyers Have Adopted the Brand as their Usual Brand Proportion of Newport Non-Menthol Adopters A total of 68% of Newport Non-Menthol purchasers are 32% adopters — claiming that Other Newport Non-Menthol is their 68% Purchasers usual brand (the one that
Slide 63: Success in Discount Plays a Supporting Role
Success in Discount Plays a Supporting Role and Is Another Opportunity Maverick Unit Volume Trends +31.5% +50.8% • Highly +60.5% Incremental +34.3% • Profitable • Increase Merchandising Presence 1.4B 4.6B Source: Management Science Associates, Inc. domestic shipment data. 63
Slide 64: Consumers Rank Maverick Highly On Key Attributes
Consumers Rank Maverick Highly On Key Attributes Six Most Important Decision Criteria for a Discount Brand Maverick perception Consumer Feedback vs. competition Good value for the money # 1 Offers lowest prices # 1 Strength of flavor I most like # 1 Has the best taste # 1 Tastes the same every time
Slide 65: Lot of Room to Measurably Grow Discount Cigarettes
There Is a Lot of Room to Measurably Grow Total Discount Cigarettes Maverick 5.1% All Others 94.9% Source: Management Science Associates, Inc. domestic shipment data. 65
Slide 66: Further Adjacent Opportunity Exists Beyond Cigarettes
Further Adjacent Opportunity Exists Beyond Cigarettes U.S. Tobacco Market Value by Segment CAGR CAGR (‘05 — ‘09) (‘09 — ‘14) $120B Smoking $113.8B Tobacco 3.5% 4.6% $110B Cigars 14.6% 2.3% Smokeless Tobacco 8.3% 7.9% $100B $96.0B $90B $82.5B Cigarettes $80B 3.1% 3.2% $70B $0B 2005 2009 2014E Source:
Slide 67: Altria and Reynolds Have Acquired Into Cigars and Smokeless
Altria and Reynolds Have Acquired Into Cigars and Smokeless Altria Revenue* Reynolds Revenue* CAGR CAGR $15.2B $16.9B $8.5B $8.6B 100% 2.7% 100% 0.1% Wine All Other Cigars All Other Smokeless & Cigars Smokeless Smokeless & Cigars 80% 80% Cigarettes Cigarettes Cigarettes Cigarettes 0% 0% 2006 2010 20
Slide 68: Lorillard Has Outperformed Them WITHOUT Acquisitions
Lorillard Has Outperformed Them WITHOUT Acquisitions Lorillard Revenue (Excludes Excise Tax) $3.1B $4.1B CAGR 7.3% Cigarettes Cigarettes 2006 Revenue 2010 Revenue Source: Lorillard filings 68
Slide 69: No Immediate Need to Enter Cigars or MST
There Is No Immediate Need nor Strategic Imperative to Enter Cigars or MST Right Now • Cigars and MST are both attractive categories, likely requiring acquisition to enter • However, even if we did want to go forward, there are significant challenges - Valuation - Branding • Cigar and MST acquisitio
Slide 70: Question #2 Answer: Many Close-In Opportunities
Question #2 Can we grow beyond our current core business? Yes...there are many close-in opportunities and the initiatives to take advantage of them are already underway and producing results, comprising over half of our first quarter 2011 volume growth. Geographic expansion Non-full flavor menthol N
Slide 71: We Start with a Committed Workforce
We Start with a Committed Workforce Net Promoter Score (%) Other Company Benchmark How likely would you be to recommend Lorillard as a place to work to a friend or relative? Source: 2010 Lorillard organizational survey 72
Slide 72: Past Efforts to Grow Beyond the Core Less than Successful
But Our Past Efforts to Grow Beyond the Core Have Been Less than Successful 1981 1998 2007 2008 1998 7 73
Slide 73: Building Several Key Capabilities To Pursue Adjacent Growth
We are Building Several Key Capabilities To Pursue Adjacent Growth Adjacent Core Expansion Product Development Sales Execution Brand Marketing Direct Mail Regulatory Affairs 74
Slide 74: Stage & Gate New Product Process
Building in Process where Needed, i.e., Stage & Gate New Product Process Project Concept Initiation Stage 1 Stage 2 Stage 3 Stage 4 Stage 5 Business Commercial Project Testing & & Concept & Launch Technical Technical Analysis Validation Analysis Development Gate 1 Gate Gate 3 Gate 2 4 Proof Proof Po
Slide 75: Hiring Key Talent Where Needed
Hiring Key Talent Where Needed • Senior Vice President, Regulatory Compliance - Hired May 2, 2011 • Director, Product Development - Hired March 28, 2011 • Director, New Products Marketing - Hired April 18, 2011 76
Slide 76: Not Distracting our Current Organization Will Be a Key Priority
Not Distracting our Current Organization Will Be a Key Priority Team 1 Team 2 Protect Responsibly And Grow Pursue Adjacent The Core Expansion 77
Slide 77: Adjacency Expansion Pursued Through Rigorous Prioritization Criteria
Once Capabilities Are in Place, Adjacency Expansion Will Be Pursued Through Rigorous Prioritization Criteria Relatedness Relatedness to the core drives success Leadership Create a path to leadership Profit Pools Target large or growing markets (attractive profit pools) Consumer Follow the consumer &
Slide 78: Question #3: Do we have the capabilities?
Question #3 Do we have the capabilities to successfully pursue additional growth opportunities? Yes... and No. Organize around the work Building in process Hiring key talent Ensuring protection of the core 79
Slide 79: Three-Prong Strategy Going Forward
Three-Prong Strategy Going Forward - We Don’t Concede Growth in Cigarettes 80
Slide 80: Having a powerful vision brings strategy to life
Having a powerful vision brings strategy to life 81
Slide 81: Lorillard Vision
Lorillard Vision 82
Slide 82: Lorillard Vision: Stakeholders, Compliance, Quality
Lorillard Vision • Stakeholders • Compliance • Quality 83
Slide 83: Lorillard Vision: A Call to Action
Lorillard Vision • A Call to Action • Excellence Across the Value Chain 84
Slide 84: Lorillard Vision: Superior Products
Lorillard Vision • Superior Products • Delight Our Consumers • Consistent Message 85
Slide 85: Lorillard Vision: Not Just FF Menthol Smokers in the Core
Lorillard Vision • Not Just FF Menthol Smokers in the Core
Slide 86: Lorillard Vision
Lorillard Vision
Slide 87: In Summary
In Summary 1. Lorillard has a demonstrated track record of results; protecting our strong core must be top priority 2. There are many avenues for growth for Lorillard and the most attractive are close-in 3. We have a great organization that will be able to deliver if we address the key capability ga
Slide 88: Break
Break 89
Slide 89: Ron Milstein, SVP Legal & External Affairs, General Counsel
Ron Milstein SVP, Legal & External Affairs, General Counsel & Secretary 90
Slide 90: Question #4: Will litigation or regulatory environment impact our potential?
Question #4 Will the litigation or regulatory environment impact our potential? 91
Slide 91: Lorillard litigation
Lorillard litigation 92
Slide 92: Lorillard Litigation
Lorillard Litigation • History of successfully managing tobacco litigation • Comprehensive disclosure in Lorillard’s recent forms 10-K and 10-Q • Will continue to vigorously defend in all such cases
Slide 93: Lorillard Litigation (cont.)
Lorillard Litigation (cont.) • Product liability litigation - Individual - Class actions - Health-Care Reimbursement - Kent filter/worker • Other litigation - FDA conflicts of interest suit - FDA advertising suit
Slide 94: Individual Cases
Individual Cases • Damages for injuries caused by smoking or exposure to ETS • Brought by smoker or family of deceased smoker (wrongful death) • Three unique types - - Traditional individual cases - Engle Progeny suits - West Virginia Mass Litigation Panel cases (“MLP”)
Slide 95: Individual Smoking and Health Cases
Individual Smoking and Health Cases Number of Individual Smoking and Health Cases Filed Against Lorillard January 1, 2002 — April 15, 2010 96
Slide 96: Evans v. Lorillard (state court, MA)
Evans v. lorillard (state court, ma)
Slide 97: Engle Cases
Engle Cases • Started as class action on behalf of Florida smokers with tobacco-related illnesses • Trial ended in $145 billion punitive damages award • In 2006, Florida Supreme Court: - vacated award — decertified the class - ruled that individual class members could file suits by January 2008 97
Slide 98: Engle Cases (cont.)
Engle Cases (cont.) • Former class members permitted to use adverse findings from class action trial in individual cases to establish liability - How findings can be used is issue in cases - Findings of class action jury not specific as to defendant’s conduct or smoking history of individual 98
Slide 99: Engle Cases (cont.)
Engle Cases (cont.) • Approximately 6,400 pending cases industry wide - 4,400 Federal cases - 2,700 State cases
Slide 100: Circuit Court of Appeals decision (Brown)
• 11 th Circuit Court of Appeals decision (Brown) - Court held that class findings cannot relieve plaintiff’s burden of proof absent a specific showing - State courts generally disagree with Brown decision - Role of findings is constitutional issue - Appeals though FL and U.S. Supreme Court likely 9
Slide 101: Engle Cases (cont.)
Engle Cases (cont.) • Verdicts returned in 44 Engle cases to date industry wide - 29 verdicts for compensatory or punitive damages • Ranging from $270,000 to $244 million (punitive damages) - 15 verdicts in favor of defendants 100
Slide 102: Engle Cases (cont.)
Engle Cases (cont.) • Lorillard was a defendant in three Engle verdicts — one case won — two cases lost Tullo: — $225,000 in compensatory damages: — no punitive damages awarded Sulcer: - $11,250 in compensatory damages: - Lorillard may appeal loss • Four cases are scheduled for trial against Lorilla
Slide 103: West Virginia MLP
West Virginia MLP • Consolidation of 700 individual cases in West Virginia state court • 35 cases involve claims against Lorillard • Multi-phase trial, with common issues proceeding first, then individual trials if necessary • Trial likely later this year 102
Slide 104: Class Actions
Class Actions • Brought on behalf of groups or classes of plaintiffs • Smoking-related diseases, addiction, medical monitoring, and smoking cessation • Common issues must predominate over individual issues • Two active suits - Scott — US Supreme court considering review - Brown — California class of
Slide 105: Health Care Reimbursement
Health Care Reimbursement • Seek recovery of health care costs for smoking-related illnesses • Brought by governmental and private plaintiffs • US Department of Justice case - Reimbursement claim rejected - Injunction in place but parties dealing with specific terms • City of St. Louis - Hospitals s
Slide 106: Kent Filter/Worker
Kent Filter/Worker • Allege injury from asbestos in original Kent cigarette filter - Manufactured between 1952 and 1956 - Usually involve mesothelioma - Smoking and health not an issue • Worker claims from asbestos exposure • Smoker claims - 36 pending suits • Verdicts have been returned in five cas
Slide 107: FDA
FDA • FDA conflicts of interest suit brought by Lorillard (and RJR) - Filed in March before TPSAC report - Alleges violation of FACA and APA - Injunction hearing likely in Fall, 2011 • FDA advertising suit brought by Lorillard (and RJR) in Kentucky - Challenges aspects of tobacco act’s advertising a
Slide 108: Act effective in June of 2010
+ Act effective in June of 2010 * Key requirements — Applications for substantial equivalence — March 2011 — Good Manufacturing Practices — compliance no earlier than June 2012 — Graphic health warnings — September 2012 * Tobacco Products Scientific Advisory Committee (TPSAC)
Slide 109: Impact of FDA Regulation
Impact of FDA Regulation • Act effective in June of 2010 • Key requirements - Applications for substantial equivalence — March 2011 - Good Manufacturing Practices — compliance no earlier than June 2012 - Graphic health warnings — September 2012 • Tobacco Products Scientific Advisory Committee (TPSAC
Slide 110: Lorillard Preparedness
Lorillard Preparedness • Plant is getting ready • Scientific affairs expanded roles • Chief Compliance Officer started May 2 nd • Consultants hired to develop overall compliance framework Many of America’s most successful companies are regulated by FDA 109
Slide 111: A Menthol Ban Is Unjustifiable
We Continue To Believe That A Menthol Ban Is Unjustifiable • The best available scientific evidence does not support an assertion that menthol in cigarettes negatively or disproportionately impacts the public health • Banning menthol would dramatically expand the cigarette “black market”, making it
Slide 112: The Ultimate Validation Lies With The FDA
The Ultimate Validation Lies With The FDA Margaret Hamburg FDA Commissioner
Slide 113: Use Every Avenue To Make Sure The FDA Follows The Science
The Company Will Use Every Avenue To Make Sure The FDA Follows The Science Lorillard Legal Science Personal Contraband Freedom Interested Media Minority Groups 112
Slide 114: Evaluates the Unintended Consequences
And, per Congress, Evaluates the Unintended Consequences 72% of Current Menthol Sales Estimate based on Compass Lexecon Report Black Market will be significant Counterfeit cigarettes with unknown ingredients Self-mentholation $10 Billion Increased youth access 500,000 American jobs at risk Lost gove
Slide 115: Question #4 Answer
Question #4 Will the litigation or regulatory environment impact our potential? No... Prepared to vigorously defend our freedom to operate Lower overall litigation profile Significant restrictions on menthol unlikely Proactively preparing for compliance 114
Slide 116: David Taylor, EVP Finance & Planning, CFO
David Taylor EVP, Finance & Planning Chief Financial Officer
Slide 117: Question #5: Can We Continue To Deliver Industry Leading Returns?
Question #5 Can We Continue To Deliver Industry Leading Returns?
Slide 118: Recent Results
Recent Results Lorillard financial performance summary 2009 2010% Change Net Sales $5,233 $5,932 +13% Operating Costs 3,692 4,207 Operating Income 1,541 1,725 +12% Taxes & Other 593 696 Net Income $948 $1,029 +8% Earnings Per Share $5.76 $6.78 +18% (Amounts in millions, except per share data) 117 So
Slide 119: Recent Results: Success continues into 2011
Recent Results Success continues into 2011 Q1 2010 Q1 2011% Change Net Sales $1,360 $1,535 +13% Operating Costs 978 1,113 Operating Income 382 421 +10% Taxes & Other 150 173 Net Income $232 $249 +7% Earnings Per Share $1.50 $1.71 +14% (Amounts in millions, except per share data) 118 Source: Lorillar
Slide 120: Industry Comparison — Volume 2005-2010
Industry Comparison — Volume 2005-2010 Total Domestic Cigarette Sales Volume 110 +1.2% CAGR to 100 100 Indexed 90 80 -5.1% Volume CAGR 70 60 2005 2006 2007 2008 2009 2010 Lorillard Rest of Industry Source: 2010 Management Science Associates, Inc. domestic shipment data. 119
Slide 121: Peer Comparison — Cigarette Profitability
Peer Comparison — Cigarette Profitability Adjusted Operating Profit Per 1,000 Units
Slide 122: Total Cash Returned to Shareholders
Total Cash Returned to Shareholders Total Dividends and Share Repurchases as a percentage of Market Cap* * Since Lorillard separation from Loews Corp. on June 9, 2008, through March 31, 2011; market cap as of March 31, 2011 Source: Company filings.
Slide 123: Reduced Shares Outstanding By 17% Since 2008
Lorillard Has Reduced Shares Outstanding By 17% Since 2008* Total Lorillard Shares Outstanding * Since Lorillard separation from Loews Corp. on June 9, 2008; as of March 31, 2011. Source: Lorillard filings.
Slide 124: Core Will Continue To Be The Foundation
Core Will Continue To Be The Foundation • Stable volume with price growth provide leverage for superior income dynamics • Successful marketing and promotional strategies that were fundamental will not be abandoned • Every reason to believe that we will continue to be successful in the core
Slide 125: Growth Strategies Beyond Core Are Incremental
Growth Strategies Beyond Core Are Incremental • Newport Non-Menthol contributes to earnings • Geographic initiatives are self-funding and generate incremental volume • Disciplined approach to new products and markets to maintain profitability • Manufacturing capacity adequate for growth • Capital ex
Slide 126: Lean Cost Structure
Lean Cost Structure • Continued focus on tight cost controls to protect operating margins • Investments in additional capabilities not material - Headcount - Market research / product tests - $10 — 15 million • Potential capital investment required for FDA compliance unknown 125
Slide 127: Capital Deployment
Capital Deployment • Capital expenditure requirements expected to be modest • Acquisitions not a priority • Cash to shareholders - Dividends • Increased twice in last 12 months • Target payout ratio 70 — 75% • Dividend will increase as earnings grow - Share repurchases • $2.0 billion through 2010 •
Slide 128: Leverage Target Not Yet Reached
Leverage Target Not Yet Reached • Target remains ~1.5x EBITDA* • Maintain investment grade ratings - Moody’s: Baa2 - S&P: BBB- - Preserve access to capital markets • Maintain flexibility • Reduce cost of capital * Total Debt to Earnings Before Interest, Taxes, Depreciation & Amortization
Slide 129: Top Tobacco Industry Performer
Top Tobacco Industry Performer Revenue Growth 7.0% #1 EPS Growth 9.2% #1 Dividend Growth* 14.8% #1 Market Share Growth +3.1 pts. #1 * Since Lorillard separation from Loews Corp. on June 9, 2008; through March 31, 2011. Source: Company filings.
Slide 130: Also a Top Consumer Goods Company
Also a Top Consumer Goods Company Revenue Growth 7.0% 5.9% EPS Growth 9.2% 7.7% Dividend Growth** 14.8% 10.1% * CPG Median reflects the median of the 36 companies included in the S&P Consumer Staples Index. ** Since Lorillard separation from Loews Corp. on June 9, 2008; through March 31, 2011. Sourc
Slide 131: Question #5 Answer: Yes
Question #5 Can We Continue To Deliver Industry Leading Returns? Yes — Operating and financial strategies are designed to continue this trend High operating leverage from organic growth Lean cost structure Further financial leverage Cash returns to shareholders
Slide 132: Strategic Plan Summary
Strategic Plan Summary 1. Priority #1 — To Protect & Grow the Core 2. Build Out Process & Capabilities 3. Pursue Close-in Adjacencies — “Cigarettes First” 4. Vigorously Defend Our Freedom to Operate 5. Organic Growth & Leading Cost Structure Leads to Superior Financial Performance 6. Emphasis on Ret
Slide 133: Lorillard Vision
Lorillard Vision
Slide 134: Appendix A: Regulation G Reconciliations
Appendix A Regulation G Reconciliations Reconciliation of Net Income to EBITDA ($ in millions) Period Ending 2006 2007 2008 2009 2010 Net Income $826 $898 $887 $948 $1,029 Add: Income Taxes 518 485 547 571 606 Other (Income) Expense, net (103) (109) (19) 22 90 Operating Income $1,241 $1,274 $1,415 $